FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Hainsworth

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
John D Hainsworth; William C Penley; Dianna L Shipley; Dana S Thompson; David M Waterhouse; Charles D Webb; F Anthony Greco
Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium.
John D Hainsworth; Raven Quinn; Samuel Raby; Mark S Rubin; David R Spigel; Ralph V Boccia; F Anthony Greco
Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.
David R Spigel; David M Waterhouse; Charles D Webb; John D Zubkus; F Anthony Greco; Howard A Burris; Martin J Bury; Victor G Gian; Lowell L Hart; Jeffrey R Infante; Dianna L Shipley; John D Hainsworth
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Hainsworth (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: John D Hainsworth; William C Penley; Dianna L Shipley; Dana S Thompson; David M Waterhouse; Charles D Webb; F Anthony Greco
Sorafenib and Everolimus in Advanced Clear Cell Renal Carcinoma: A Phase I/II Trial of the SCRI Oncology Research Consortium.
Cancer investigation 2013;31(5):323-9.
2013: John D Hainsworth; Raven Quinn; Samuel Raby; Mark S Rubin; David R Spigel; Ralph V Boccia; F Anthony Greco
Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(2):217-23.
2012: David R Spigel; David M Waterhouse; Charles D Webb; John D Zubkus; F Anthony Greco; Howard A Burris; Martin J Bury; Victor G Gian; Lowell L Hart; Jeffrey R Infante; Dianna L Shipley; John D Hainsworth
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2012;78(1):70-5.
2012: David R Spigel; Dana S Thompson; Howard A Burris; Janice F Eakle; F Anthony Greco; Eric T Lubiner; Raven Quinn; Mark S Rubin; Dianna L Shipley; John D Hainsworth
Phase II study of maintenance sunitinib following irinotecan and carboplatin as first-line treatment for patients with extensive-stage small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2012;77(2):359-64.
2012: Johanna C Bendell; Howard A Burris; Anthony Meluch; James Peyton; Mark Rubin; David Waterhouse; Charles Webb; John D Hainsworth
A phase II trial of preoperative concurrent chemotherapy/radiation therapy plus bevacizumab/erlotinib in the treatment of localized esophageal cancer.
Clinical advances in hematology & oncology : H&O 2012;10(7):430-7.
2012: John D Hainsworth; Catherine A Schnabel; Mark G Erlander; David W Haines; F Anthony Greco
A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile.
Clinical colorectal cancer 2012;11(2):112-8.
2012: John D Hainsworth; Gregg C Shepard; Kent C Shih; Brett T Brinker; Guy W Tillinghast; David R Spigel
Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.
Clinical advances in hematology & oncology : H&O 2012;10(4):240-6.
2012: David R Spigel; Jeffrey R Infante; Michael McCleod; Dianna L Shipley; Edward Arrowsmith; E Kirk Barnes; Johanna C Bendell; Howard A Burris; F Anthony Greco; John D Hainsworth
Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer.
Clinical colorectal cancer 2012;11(1):45-52.
2011: Denise A Yardley; Howard A Burris; Raul Castillo; Anup Lahiry; Richard Locicero; Eric Raefsky; Mythili Shastry; Dana Thompson; John D Hainsworth
Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer.
Clinical breast cancer 2011;11(5):297-305.
2011: John D Hainsworth; F Anthony Greco; James Peyton; Mark Rubin; Dianna L Shipley; David R Spigel; Michael Stipanov; Anthony Meluch
Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck: a phase II trial of the Sarah Cannon oncology research consortium.
Cancer journal (Sudbury, Mass.) 2011;17(5):267-72.
2011: John D Hainsworth; Jeffrey R Infante; David R Spigel; Edward R Arrowsmith; Ralph V Boccia; Howard A Burris
A phase II trial of panobinostat, a histone deacetylase inhibitor, in the treatment of patients with refractory metastatic renal cell carcinoma.
Cancer investigation 2011;29(7):451-5.
2011: David R Spigel; David M Waterhouse; Robert C Whorf; Jeffrey Zangmeister; J David Bass; Howard A Burris; Davey B Daniel; Elke K Friedman; F Anthony Greco; R Brian Mitchell; Dianna L Shipley; John D Hainsworth
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(18):2582-9.
2011: Denise A Yardley; Mark Rubin; Dianna L Shipley; Edward Arrowsmith; John Barton; Howard A Burris; Bobby L Clark; John D Hainsworth
Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology Research Consortium.
Clinical breast cancer 2011;11(3):146-52.
2011: David R Spigel; Robert C Whorf; Dianna L Shipley; Edward R Arrowsmith; Howard A Burris; Bobby L Clark; F Anthony Greco; John D Hainsworth
A phase II study of higher dose weekly topotecan in relapsed small-cell lung cancer.
Clinical lung cancer 2011;12(3):187-91.
2011: David R Spigel; John D Hainsworth; Howard A Burris; David C Molthrop; Nancy Peacock; Michael Kommor; Elizabeth R Vazquez; F Anthony Greco; Denise A Yardley
A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer.
Clinical advances in hematology & oncology : H&O 2011;9(4):280-6.
2011: John D Hainsworth; Liang Fang; Jane E Huang; David Karlin; Kenneth Russell; Leonardo Faoro; Christopher Azzoli
BRIDGE: an open-label phase II trial evaluating the safety of bevacizumab + carboplatin/paclitaxel as first-line treatment for patients with advanced, previously untreated, squamous non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(1):109-14.
2011: Jeffrey R Infante; Suzanne F Jones; Johanna C Bendell; David R Spigel; Denise A Yardley; Colin D Weekes; Wells A Messersmith; John D Hainsworth; Howard A Burris
A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancer.
European journal of cancer (Oxford, England : 1990) 2011;47(2):199-205.
2010: Denise A Yardley; Michael McCleod; Fred Schreiber; Patrick Murphy; Jeffrey Patton; Dana S Thompson; Mythili Shastry; Mark Rubin; Marianne Melnik; Howard A Burris; John D Hainsworth
A phase II trial of vinflunine as monotherapy or in combination with trastuzumab as first-line treatment of metastatic breast cancer.
Cancer investigation 2010;28(9):925-31.
2010: John D Hainsworth; Cristina L Cebotaru; Vladimir Kanarev; Tudor E Ciuleanu; Danail Damyanov; Phillip Stella; Hristo Ganchev; Gillian Pover; Clive Morris; Valentina Tzekova
A phase II, open-label, randomized study to assess the efficacy and safety of AZD6244 (ARRY-142886) versus pemetrexed in patients with non-small cell lung cancer who have failed one or two prior chemotherapeutic regimens.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(10):1630-6.
2010: Denise A Yardley; Davey Daniel; Michael Stipanov; D Randolph Drosick; Mark Mainwaring; James Peyton; Mythili Shastry; John D Hainsworth
A phase II trial of oxaliplatin and trastuzumab in the treatment of HER2-positive metastatic breast cancer.
Cancer investigation 2010;28(8):865-71.
2010: Denise A Yardley; John Zubkus; Brooke Daniel; Roger Inhorn; Cassie M Lane; Elizabeth R Vazquez; Yuval Naot; Howard A Burris; John D Hainsworth
A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer.
Clinical breast cancer 2010;10(5):367-72.
2010: John D Hainsworth; Jeffrey R Infante; David R Spigel; James D Peyton; Dana S Thompson; Cassie M Lane; Bobby L Clark; Mark S Rubin; David F Trent; Howard A Burris
Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
Cancer 2010;116(17):4122-9.
2010: John D Hainsworth; Thomas Ervin; Elke Friedman; Victor Priego; Patrick B Murphy; Bobby L Clark; Ruth E Lamar
Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
Cancer 2010;116(15):3663-9.
2010: David R Spigel; F Anthony Greco; David Waterhouse; Dianna L Shipley; Cassie M Lane; Elizabeth R Vazquez; Bobby L Clark; Jeffrey R Infante; Johanna C Bendell; Howard A Burris; John D Hainsworth
Phase II trial of FOLFOX6, bevacizumab, and cetuximab in the first-line treatment of metastatic colorectal cancer.
Clinical advances in hematology & oncology : H&O 2010;8(7):480-5, 498.
2010: David R Spigel; John D Hainsworth; Cassie M Lane; Bobby Clark; Howard A Burris; F Anthony Greco
Phase II trial of vinflunine in relapsed small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(6):874-8.
2010: David R Spigel; John D Hainsworth; Jitendra G Gandhi; Victor G Gian; James D Peyton; Kimberly West-Osterfield; Bobby L Clark; Elizabeth R Vazquez; Suzanne F Jones; Howard A Burris; F Anthony Greco
A phase II trial of carboplatin and weekly topotecan in the first-line treatment of patients with extensive stage small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(6):862-6.
2010: Denise A Yardley; Nancy W Peacock; Natalie R Dickson; Melissa B White; Elizabeth R Vázquez; John T Foust; Richard Grapski; Linda K Hendricks; William L Scott; John D Hainsworth
A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer.
Clinical breast cancer 2010;10(3):217-23.
2010: John D Hainsworth; David R Spigel; Howard A Burris; Dianna L Shipley; Cindy Farley; Ines M Macias-Perez; John Barton; F Anthony Greco
Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.
Cancer 2010;116(10):2448-54.
2010: David R Spigel; F Anthony Greco; Dana S Thompson; Charles Webb; James Rubinsak; Roger C Inhorn; James Reeves; Elizabeth R Vazquez; Cassie M Lane; Howard A Burris; John D Hainsworth
Phase II study of cetuximab, docetaxel, and gemcitabine in patients with previously untreated advanced non-small-cell lung cancer.
Clinical lung cancer 2010;11(3):198-203.
2010: John D Hainsworth; David R Spigel; Howard A Burris; David Waterhouse; Bobby L Clark; Robert Whorf
Phase II trial of bevacizumab and everolimus in patients with advanced renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2131-6.
2010: David R Spigel; F Anthony Greco; Anthony A Meluch; Cassie M Lane; Cynthia Farley; James R Gray; Bobby L Clark; Howard A Burris; John D Hainsworth
Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(13):2213-9.
2010: Howard A Burris; Suzanne F Jones; Dianna Shipley; Anthony A Meluch; F Anthony Greco; John H Barton; Denise A Yardley; John D Hainsworth
Phase II study of capecitabine in combination with thalidomide in patients with metastatic breast cancer.
Cancer investigation 2010;28(4):408-12.
2010: John D Hainsworth; Anthony A Meluch; Cassie M Lane; David R Spigel; Howard A Burris; Jitendra G Gandhi; Edward J Crane; Michael A Stipanov; F Anthony Greco
Single agent vinflunine in the salvage treatment of patients with castration-resistant prostate cancer: a phase II trial of the Sarah Cannon research consortium.
Cancer investigation 2010;28(3):275-9.
2010: John D Hainsworth; Ian W Flinn; David R Spigel; Bobby L Clark; Paula L Griner; Elizabeth R Vazquez; Habib H Doss; Dianna Shipley; Luis A Franco; Howard A Burris; F Anthony Greco
Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research Consortium.
Clinical lymphoma, myeloma & leukemia 2010;10(1):44-50.
2010: David R Spigel; John D Hainsworth; Denise A Yardley; Eric Raefsky; Jeffrey Patton; Nancy Peacock; Cindy Farley; Howard A Burris; F Anthony Greco
Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):43-8.
2009: John D Hainsworth; David R Spigel; Dana S Thompson; Patrick B Murphy; Cassie M Lane; David M Waterhouse; Yuval Naot; F Anthony Greco
Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site.
The oncologist 2009;14(12):1189-97.
2009: David R Spigel; F Anthony Greco; John D Zubkus; Patrick B Murphy; Ruben A Saez; Cindy Farley; Denise A Yardley; Howard A Burris; John D Hainsworth
Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(12):1555-60.
2009: Denise A Yardley; Howard A Burris; David R Spigel; Bobby L Clark; Elizabeth Vazquez; Dianna L Shipley; John Barton; Dana Thompson; Ignacio Montes; F Anthony Greco; John D Hainsworth
A phase II randomized crossover study of liposomal doxorubicin versus weekly docetaxel in the first-line treatment of women with metastatic breast cancer.
Clinical breast cancer 2009;9(4):247-52.
2009: Denise A Yardley; Howard A Burris; Tiffanie M Markus; David R Spigel; F Anthony Greco; Mark Mainwaring; David M Waterhouse; Charles D Webb; John D Hainsworth
Phase II trial of docetaxal plus imatinib mesylate in the treatment of patients with metastatic breast cancer.
Clinical breast cancer 2009;9(4):237-42.
2009: Denise A Yardley; Howard A Burris; Sarah Hanson; F Anthony Greco; David R Spigel; John Barton; John D Hainsworth
Weekly gemcitabine and trastuzumab in the treatment of patients with HER2-overexpressing metastatic breast cancer.
Clinical breast cancer 2009;9(3):178-83.
2009: John D Hainsworth; David R Spigel; Tiffanie M Markus; Dianna L Shipley; Dana Thompson; Richard Rotman; Charles Dannaher; F Anthony Greco
Rituximab plus short-duration chemotherapy followed by Yttrium-90 Ibritumomab tiuxetan as first-line treatment for patients with follicular non-Hodgkin lymphoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
Clinical lymphoma & myeloma 2009;9(3):223-8.
2009: John D Hainsworth; David R Spigel; Howard A Burris; Tiffanie M Markus; Dianna L Shipley; Michel Kuzur; Scott Lunin; F Anthony Greco
Neoadjuvant chemotherapy/gefitinib followed by concurrent chemotherapy/radiation therapy/gefitinib for patients with locally advanced squamous carcinoma of the head and neck.
Cancer 2009;115(10):2138-46.
2009: Jeffrey R Infante; Denise A Yardley; Howard A Burris; F Anthony Greco; Cindy P Farley; Charles Webb; David R Spigel; John D Hainsworth
Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer.
Clinical breast cancer 2009;9(1):23-8.
2009: John D Hainsworth; Karim Fizazi
Treatment for patients with unknown primary cancer and favorable prognostic factors.
Seminars in oncology 2009;36(1):44-51.
2008: Denise A Yardley; Howard A Burris; Lisa Simons; David R Spigel; F Anthony Greco; John H Barton; Dianna L Shipley; David Drosick; John D Hainsworth
A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer.
Clinical breast cancer 2008;8(5):425-31.
2008: John D Hainsworth; David R Spigel; John Barton; Cindy Farley; Marshall Schreeder; Jeremy Hon; F Anthony Greco
Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
Cancer 2008;113(4):765-71.
2008: David R Spigel; Ming Lin; Vincent O'Neill; John D Hainsworth
Final survival and safety results from a multicenter, open-label, phase 3b trial of erlotinib in patients with advanced nonsmall cell lung cancer.
Cancer 2008;112(12):2749-55.
2008: Denise A Yardley; Howard A Burris; Cindy P Farley; John H Barton; Nancy W Peacock; David R Spigel; F Anthony Greco; John D Hainsworth
A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer.
Clinical breast cancer 2008;8(3):242-8.
2008: John D Hainsworth; Elizabeth R Vazquez; David R Spigel; Eric Raefsky; James Bearden; Ruben A Saez; F Anthony Greco
Combination therapy with fludarabine and rituximab followed by alemtuzumab in the first-line treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
Cancer 2008;112(6):1288-95.
2007: John D Hainsworth; David R Spigel; Jeffrey A Sosman; Howard A Burris; Cindy Farley; Heather Cucullu; Kathleen Yost; Lowell L Hart; Linda Sylvester; David M Waterhouse; F Anthony Greco
Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trial.
Clinical genitourinary cancer 2007;5(7):427-32.
2007: John D Hainsworth; David R Spigel; Cindy Farley; Dianna L Shipley; James Bearden; Jitendra Gandhi; Gerry Ann Houston; F Anthony Greco
Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network.
Cancer 2007;110(9):2027-34.
2007: F Anthony Greco; David R Spigel; Michel E Kuzur; Dianna L Shipley; James R Gray; Dana S Thompson; Howard A Burris; Denise A Yardley; Asim Pati; Charles D Webb; Jitendra G Gandhi; John D Hainsworth
Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.
Clinical lung cancer 2007;8(8):483-7.
2007: David R Spigel; John D Hainsworth; Lisa Simons; Christina Meng; Howard A Burris; Denise A Yardley; Richard Grapski; Marshall Schreeder; Padmaja V Mallidi; F Anthony Greco
Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(9):854-61.
2007: John D Hainsworth; David R Spigel; Cindy Farley; Dana S Thompson; Dianna L Shipley; F Anthony Greco
Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1747-52.
2007: John D Hainsworth; Anthony A Meluch; David R Spigel; John Barton; Lisa Simons; Christina Meng; Bruce Gould; F Anthony Greco
Weekly docetaxel and bortezomib as first-line treatment for patients with hormone-refractory prostate cancer: a Minnie Pearl Cancer Research Network phase II trial.
Clinical genitourinary cancer 2007;5(4):278-83.
2006: John D Hainsworth; Denise A Yardley; David R Spigel; Anthony A Meluch; David A Rinaldi; Frederick M Schnell; F Anthony Greco
Docetaxel and epirubicin as first-line treatment for patients with metastatic breast cancer: a Minnie Pearl Cancer Research Network Phase II trial.
Cancer investigation 2006;24(5):469-73.
2006: John D Hainsworth; David R Spigel; Sharlene Litchy; F Anthony Greco
Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3548-54.
2006: John D Hainsworth; Anthony A Meluch; David R Spigel; Kathleen Yost; Christina Meng; F Anthony Greco
Weekly docetaxel/estramustine phosphate in patients with increasing serum prostate- specific antigen levels after primary treatment for prostate cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Clinical genitourinary cancer 2006;4(4):287-92.
2005: John D Hainsworth; Jeffrey A Sosman; David R Spigel; Donna L Edwards; Cara Baughman; Anthony Greco
Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):7889-96.
2005: Suzanne F Jones; F Anthony Greco; Victor G Gian; Fernando T Miranda; Eric L Raefsky; John D Hainsworth; Noel T Willcutt; Aurelia F Beschorner; Glyndon Kennerly; Howard A Burris
A Phase I trial of protracted oral fixed-dose temozolomide.
Cancer 2005;104(9):1985-91.
2005: John D Hainsworth; David R Spigel; Eric L Raefsky; Michel E Kuzur; Kathleen Yost; Michael Kommor; Sharlene Litchy; F Anthony Greco
Combination chemotherapy with gemcitabine and irinotecan in patients with previously treated carcinoma of an unknown primary site: a Minnie Pearl Cancer Research Network Phase II trial.
Cancer 2005;104(9):1992-7.
2005: F Anthony Greco; Dana S Thompson; Lisa H Morrissey; Joan B Erland; Howard A Burris; David R Spigel; Geetha Joseph; Stephen Corso; Ellen Spremulli; John D Hainsworth
Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial.
The oncologist 2005;10(9):728-33.
2005: David R Spigel; John D Hainsworth; Emily R Burkett; Howard A Burris; Denise A Yardley; Melodie Thomas; Suzanne F Jones; Natalie R Dickson; Daniel C Scullin; James E Bradof; James R Rubinsak; Joseph E Brierre; F Anthony Greco
Single-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial.
Clinical lung cancer 2005;7(2):127-32.
2005: John D Hainsworth; Anthony A Meluch; Sharlene Litchy; Frederick M Schnell; James Bearden; Kathleen Yost; F Anthony Greco
Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium.
Cancer 2005;103(11):2298-303.
2005: Suzanne F Jones; John Kuhn; F Anthony Greco; Eric L Raefsky; John D Hainsworth; Natalie R Dickson; Dana S Thompson; Noel T Willcutt; Melissa B White; Howard A Burris
A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancer.
Clinical lung cancer 2005;6(6):361-6.
2005: John D Hainsworth; Leonard Kalman; Michael Castine; Linda Sylvester; F Anthony Greco
Paclitaxel, carboplatin, and oral etoposide as initial treatment for advanced ovarian carcinoma: a Minnie Pearl Cancer Research Network phase II trial.
Gynecologic oncology 2005;97(1):200-5.
2005: John D Hainsworth; Sharlene Litchy; Lisa H Morrissey; Michael B Andrews; Manuel Grimaldi; Matthew McCarty; F Anthony Greco
Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1500-6.
2005: John D Hainsworth; Sharlene Litchy; Don W Shaffer; Van L Lackey; Manuel Grimaldi; F Anthony Greco
Maximizing therapeutic benefit of rituximab: maintenance therapy versus re-treatment at progression in patients with indolent non-Hodgkin's lymphoma--a randomized phase II trial of the Minnie Pearl Cancer Research Network.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(6):1088-95.
2004: John D Hainsworth; James R Gray; Sharlene Litchy; James Bearden; Don W Shaffer; Gerry Ann Houston; F Anthony Greco
A phase II trial of preoperative concurrent radiation therapy and weekly paclitaxel/carboplatin for patients with locally advanced non-small-cell lung cancer.
Clinical lung cancer 2004;6(1):33-42.
2004: John D Hainsworth
Prolonging remission with rituximab maintenance therapy.
Seminars in oncology 2004;31(1 Suppl 2):17-21.
2004: F Anthony Greco; Gladys I Rodriguez; Don W Shaffer; Robert Hermann; Sharlene Litchy; Denise A Yardley; Howard A Burris; Lisa H Morrissey; Joan B Erland; John D Hainsworth
Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.
The oncologist 2004;9(6):644-52.
2004: John D Hainsworth
Practical aspects of weekly docetaxel administration schedules.
The oncologist 2004;9(5):538-45.
2003: Anthony A Meluch; F Anthony Greco; Lisa H Morrissey; Eric L Raefsky; Ronald G Steis; James A Butts; John D Hainsworth
Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial.
Cancer 2003;98(10):2192-8.
2003: John D Hainsworth; Joan B Erland; John H Barton; Dana S Thompson; M Patrick Stagg; James E Bradof; Thomas W Twele; E Anthony Greco
Combination treatment with weekly docetaxel and gemcitabine for advanced non-small-cell lung cancer in elderly patients and patients with poor performance status: results of a Minnie Pearl Cancer Research Network phase II trial.
Clinical lung cancer 2003;5(1):33-8.
2003: Anthony A Meluch; F Anthony Greco; James R Gray; Melodie Thomas; Valerie M Sutton; J Lucian Davis; Leonard A Kalman; Don W Shaffer; Kathleen Yost; David A Rinaldi; John D Hainsworth
Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial.
Cancer journal (Sudbury, Mass.) 2003;9(4):251-60.
2003: John D Hainsworth; Sharlene Litchy; M Ray Lamb; Gladys I Rodriguez; Carroll Scroggin; F Anthony Greco
First-line treatment with brief-duration chemotherapy plus rituximab in elderly patients with intermediate-grade non-Hodgkin's lymphoma: phase II trial.
Clinical lymphoma 2003;4(1):36-42.
2003: John D Hainsworth; Mark G Mainwaring; Melodie Thomas; Lester L Porter; Victor G Gian; Suzanne F Jones; F Anthony Greco
Gefitinib in the treatment of advanced, refractory non-small-cell lung cancer: results in 124 patients.
Clinical lung cancer 2003;4(6):347-55.
2003: Suzanne F Jones; Victor G Gian; F Anthony Greco; Fernando T Miranda; Dianna L Shipley; Dana S Thompson; John D Hainsworth; Mitchell A Toomey; Noel T Willcutt; Howard A Burris
Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.
Oncology (Williston Park, N.Y.) 2003;17(5 Suppl 5):41-5.
2003: Suzanne F Jones; Howard A Burris; John D Hainsworth; Denise A Yardley; Eric A Raefsky; Fernando T Miranda; Michel E Kuzur; Noel T Willcutt; Melissa B White; F Anthony Greco
Phase I. Trial of irinotecan plus carboplatin in two dose schedules.
Oncology (Williston Park, N.Y.) 2003;17(5 Suppl 5):36-40.
2003: John D Hainsworth; Sharlene Litchy; John H Barton; Gerry Ann Houston; Robert C Hermann; James E Bradof; F Anthony Greco
Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1746-51.
2003: John D Hainsworth; Howard A Burris; Joan B Erland; Margaret Baker; Daniel C Scullin; Don W Shaffer; F Anthony Greco
Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Cancer investigation 2003;21(2):193-9.
2003: F Anthony Greco; John D Hainsworth
Emerging role of topotecan in first-line therapy of small-cell lung cancer.
Clinical lung cancer 2003;4(5):279-87.
2003: John D Hainsworth
First-line and maintenance treatment with rituximab for patients with indolent non-Hodgkin's lymphoma.
Seminars in oncology 2003;30(1 Suppl 2):9-15.
2003: John D Hainsworth
Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis.
Arthritis research & therapy 2003;5 Suppl 4():S12-6.
2002: John D Hainsworth
Diagnosis, staging, and clinical characteristics of the patient with mediastinal germ cell carcinoma.
Chest surgery clinics of North America 2002;12(4):665-72.
2002: John D Hainsworth; Sharlene Litchy; Howard A Burris; Daniel C Scullin; Stephen Corso; Denise A Yardley; Lisa H Morrissey; F Anthony Greco
Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(20):4261-7.
2002: F Anthony Greco; James R Gray; Dana S Thompson; Howard A Burris; Joan B Erland; John H Barton; Sharlene Litchy; Gerry Ann Houston; James A Butts; Charles Webb; Charles Scott; John D Hainsworth
Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma: a minnie pearl cancer research network trial.
Cancer 2002;95(6):1279-85.
2002: John D Hainsworth; Anthony A Meluch; Suzanne McClurkan; James R Gray; Steven L Stroup; Howard A Burris; Denise A Yardley; James E Bradof; Kathleen Yost; James K Ellis; F Anthony Greco
Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Cancer journal (Sudbury, Mass.) 2002;8(4):311-21.
2002: John D Hainsworth; James R Gray; Lisa H Morrissey; Leonard A Kalman; Jeremy K Hon; F Anthony Greco
Long-term follow-up of patients treated with paclitaxel/carboplatin-based chemotherapy for advanced non-small-cell lung cancer: sequential phase II trials of the Minnie Pearl Cancer Research Network.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(13):2937-42.
2002: John D Hainsworth; Lisa H Morrissey; Daniel C Scullin; Gerry Ann Houston; Edgar F Prasthofer; James R Gray; Howard A Burris; F Anthony Greco
Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Cancer 2002;94(9):2426-33.
2002: F Anthony Greco; Howard A Burris; Sharlene Litchy; John H Barton; James E Bradof; Paul Richards; Daniel C Scullin; Joan B Erland; Lisa H Morrissey; John D Hainsworth
Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1651-6.
2002: John D Hainsworth
Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma: interim follow-up of a multicenter phase II trial.
Seminars in oncology 2002;29(1 Suppl 2):25-9.
2002: John D Hainsworth; Sharon Calvert; F Anthony Greco
Paclitaxel and mitoxantrone in the treatment of metastatic breast cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Cancer investigation 2002;20(7-8):863-71.
2002: Suzanne F Jones; F Anthony Greco; John D Hainsworth; Jeffrey W Patton; John H Barton; Noel T Willcutt; Margaret N Baker; Paul V McGuirt; Jeremey Levin; Howard A Burris
A phase I trial of weekly paclitaxel plus prolonged oral eniluracil/5-fluorouracil in patients with refractory malignancies.
The oncologist 2002;7(5):444-50.
2001: John D Hainsworth; Howard A Burris; F T Billings; James E Bradof; Margaret Baker; F Anthony Greco
Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
Cancer 2001;92(9):2391-8.
2001: F Anthony Greco; Howard A Burris; James R Gray; Eric L Raefsky; C Dobbs; S Smith; David A Rinaldi; Lisa H Morrissey; Joan B Erland; Sharlene Litchy; John D Hainsworth
Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma: a feasibility study of the Minnie Pearl Cancer Research Network.
Cancer 2001;92(8):2142-7.
2001: John D Hainsworth; Howard A Burris; Anthony A Meluch; M N Baker; Lisa H Morrissey; F Anthony Greco
Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a Phase II trial.
Cancer 2001;92(3):642-9.
2001: John D Hainsworth; Howard A Burris; Denise A Yardley; James E Bradof; Manuel Grimaldi; Leonard A Kalman; T Sullivan; Margaret Baker; Joan B Erland; F Anthony Greco
Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(15):3500-5.
2001: Anthony A Meluch; F Anthony Greco; Howard A Burris; TJ O'Rourke; G Ortega; Ronald G Steis; Lisa H Morrissey; V Johnson; John D Hainsworth
Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):3018-24.
2001: John D Hainsworth; Howard A Burris; F Anthony Greco
Weekly docetaxel as a single agent and in combination with gemcitabine in elderly and poor performance status patients with advanced non--small cell lung cancer.
Seminars in oncology 2001;28(3 Suppl 9):21-5.
2001: F Anthony Greco; J Gray; Howard A Burris; Joan B Erland; Lisa H Morrissey; John D Hainsworth
Taxane-based chemotherapy for patients with carcinoma of unknown primary site.
Cancer journal (Sudbury, Mass.) 2001;7(3):203-12.
2001: John D Hainsworth; Howard A Burris; F Anthony Greco
Paclitaxel-based three-drug combinations for the treatment of small cell lung cancer: a review of the Sarah Cannon Cancer Center experience.
Seminars in oncology 2001;28(2 Suppl 4):43-7.
2001: John D Hainsworth; E E Vokes
Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer.
Seminars in oncology 2001;28(1 Suppl 2):22-7.
2001: John D Hainsworth; Howard A Burris; S W Calvert; Noel T Willcutt; Daniel C Scullin; J Bramham; F Anthony Greco
Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network.
Cancer investigation 2001;19(4):335-9.
2000: F Anthony Greco; Howard A Burris; Joan B Erland; James R Gray; Leonard A Kalman; Marshall Schreeder; John D Hainsworth
Carcinoma of unknown primary site.
Cancer 2000;89(12):2655-60.
2000: John D Hainsworth
Rituximab as first-line systemic therapy for patients with low-grade lymphoma.
Seminars in oncology 2000;27(6 Suppl 12):25-9.
2000: John D Hainsworth; Howard A Burris; Sharlene Litchy; Lisa H Morrissey; John H Barton; James E Bradof; F Anthony Greco
Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II Trial.
Cancer 2000;89(2):328-33.
2000: F Anthony Greco; Howard A Burris; John D Hainsworth
Gemcitabine, paclitaxel, and carboplatin for advanced non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 2000;14(7 Suppl 4):31-4.
2000: John D Hainsworth; Howard A Burris; Lisa H Morrissey; Sharlene Litchy; Daniel C Scullin; James Bearden; P Richards; F Anthony Greco
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma.
Blood 2000;95(10):3052-6.
2000: John D Hainsworth; Howard A Burris; Lisa H Morrissey; Melodie Thomas; Joan B Erland; James A Butts; G Joseph; Leonard A Kalman; F Anthony Greco
Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
Cancer journal (Sudbury, Mass.) 2000;6(3):151-6.
2000: John D Hainsworth; F Anthony Greco
Management of patients with cancer of unknown primary site.
Oncology (Williston Park, N.Y.) 2000;14(4):563-74; discussion 574-6, 578-9.
2000: John D Hainsworth; Howard A Burris; Sharlene Litchy; Joan B Erland; Jeremy K Hon; Joseph E Brierre; F Anthony Greco
Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: a minnie pearl cancer research network phase II trial.
Cancer 2000;88(6):1353-8.
2000: F Anthony Greco; Joan B Erland; Lisa H Morrissey; Howard A Burris; R C Hermann; Ronald G Steis; D Thompson; J Gray; John D Hainsworth
Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):211-5.
2000: Howard A Burris; John D Hainsworth; Joan B Erland; Lisa H Morrissey; Leonard A Kalman; Jeremy K Hon; Daniel C Scullin; S W Smith; F Anthony Greco
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer.
Seminars in oncology 2000;27(1 Suppl 2):9-13.
2000: John D Hainsworth; W J Lennington; F Anthony Greco
Overexpression of Her-2 in patients with poorly differentiated carcinoma or poorly differentiated adenocarcinoma of unknown primary site.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):632-5.
1999: John D Hainsworth; Howard A Burris; F Anthony Greco
Weekly administration of docetaxel (Taxotere): summary of clinical data.
Seminars in oncology 1999;26(3 Suppl 10):19-24.
1999: F Anthony Greco; Melodie Thomas; John D Hainsworth
One-hour paclitaxel infusions: review of safety and efficacy.
The cancer journal from Scientific American 1999;5(3):179-91.
1999: John D Hainsworth; Howard A Burris; Joan B Erland; Lisa H Morrissey; Anthony A Meluch; Leonard A Kalman; Jeremy K Hon; Daniel C Scullin; S W Smith; F Anthony Greco
Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma.
Cancer 1999;85(6):1269-76.
1999: Anthony A Meluch; John D Hainsworth; James R Gray; Melodie Thomas; P L Whitworth; J Lucian Davis; F Anthony Greco
Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
The cancer journal from Scientific American 1999;5(2):84-91.
1999: John D Hainsworth; Howard A Burris; Lisa H Morrissey; F Anthony Greco
Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte-colony stimulating factor) in the treatment of patients with advanced, refractory cancer.
Cancer 1999;85(5):1179-85.
1999: F Anthony Greco; John D Hainsworth
The evolving role of paclitaxel for patients with carcinoma of unknown primary site.
Seminars in oncology 1999;26(1 Suppl 2):129-33.
1999: John D Hainsworth; F Anthony Greco
The current role and future prospects of paclitaxel in the treatment of small cell lung cancer.
Seminars in oncology 1999;26(1 Suppl 2):60-6.
1999: John D Hainsworth
Extended-schedule oral etoposide in selected neoplasms and overview of administration and scheduling issues.
Drugs 1999;58 Suppl 3():51-6.
1999: F Anthony Greco; John D Hainsworth
Paclitaxel-based therapy in non-small-cell lung cancer: improved third generation chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 5():S63-7.
1998: John D Hainsworth; Howard A Burris; Joan B Erland; M Thomas; F Anthony Greco
Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2164-8.
1998: John D Hainsworth; W J Urba; Jeremy K Hon; K A Thompson; M P Stagg; LG Hopkins; Melodie Thomas; F Anthony Greco
One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial.
European journal of cancer (Oxford, England : 1990) 1998;34(5):654-8.
1998: F Anthony Greco; John D Hainsworth
One-hour paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
Oncology (Williston Park, N.Y.) 1998;12(1 Suppl 2):71-3.
1998: John D Hainsworth; LG Hopkins; Melodie Thomas; F Anthony Greco
Paclitaxel, carboplatin, and extended-schedule oral etoposide for small-cell lung cancer.
Oncology (Williston Park, N.Y.) 1998;12(1 Suppl 2):31-5.
1997: John D Hainsworth
Mitoxantrone, 5-fluorouracil and high-dose leucovorin (NFL) in the treatment of metastatic breast cancer: randomized comparison to cyclophosphamide, methotrexate and 5-fluorouracil (CMF) and attempts to improve efficacy by adding paclitaxel.
European journal of cancer care 1997;6(4 Suppl):4-9.
1997: F Anthony Greco; John D Hainsworth
One-hour paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of carcinoma of unknown primary site.
Seminars in oncology 1997;24(6 Suppl 19):S19-101-S19-105.
1997: John D Hainsworth; James R Gray; S L Stroup; Leonard A Kalman; J E Patten; LG Hopkins; Melodie Thomas; F Anthony Greco
Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(12):3464-70.
1997: F Anthony Greco; John D Hainsworth
Paclitaxel with mitoxantrone with or without 5-fluorouracil and high-dose leucovorin in the treatment of metastatic breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-61-S17-64.
1997: F Anthony Greco; John D Hainsworth
Paclitaxel (1-hour infusion) plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicenter phase II trial.
Seminars in oncology 1997;24(4 Suppl 12):S12-14-S12-17.
1997: John D Hainsworth; Joan B Erland; Leonard A Kalman; Marshall Schreeder; F Anthony Greco
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2385-93.
1997: John D Hainsworth; J Jolivet; R Birch; LG Hopkins; F Anthony Greco
Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Cancer 1997;79(4):740-8.
1997: John D Hainsworth; S M Utley; F Anthony Greco
Phase I study of high dose etoposide phosphatase with filgrastim (G-CSF) in the treatment of advanced refractory malignancies.
Investigational new drugs 1997;15(4):325-9.
1997: F Anthony Greco; John D Hainsworth
Multidisciplinary approach to potentially curable non-small cell carcinoma of the lung.
Oncology (Williston Park, N.Y.) 1997;11(1):27-36; discussion 41, 44, 49.